Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Farmers Insurance
Colorcon
Deloitte
Argus Health
Citi
US Army
Mallinckrodt

Generated: April 25, 2018

DrugPatentWatch Database Preview

OXYCODONE 5/APAP 500 Drug Profile

« Back to Dashboard

When do Oxycodone 5/apap 500 patents expire, and when can generic versions of Oxycodone 5/apap 500 launch?

Oxycodone 5/apap 500 is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in OXYCODONE 5/APAP 500 is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.

US Patents and Regulatory Information for OXYCODONE 5/APAP 500

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb OXYCODONE 5/APAP 500 acetaminophen; oxycodone hydrochloride TABLET;ORAL 085911-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Teva
AstraZeneca
Julphar
Cipla
McKinsey
Cerilliant
Cantor Fitzgerald
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.